Peptide Schedule
Cagrilintide37 residuesKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTYEach bubble = one amino acid. Size = residue mass. Color = chemical class.

Cagrilintide Dosage Calculator

Weight LossInjectionPhase 3~7 days half-life

Cagrilintide is a long-acting amylin receptor agonist that works through a completely different pathway than GLP-1 drugs like semaglutide.

Different mechanism than GLP-1 — targets amylin pathwayReduces cravings and appetiteSlows gastric emptying for prolonged fullnessWeekly dosing for convenience

500mcg · Weekly

100500
20.0 units
100 units (1mL)
Concentration
2,500
mcg/mL
Draw Volume
0.200
mL
Syringe Units
20.0
units
Doses / Vial
10
doses

Summary: Add 2mL BAC water to your 5mg vial. Draw to 20.0 units on a U-100 syringe for a 500mcg dose. This vial will last 10 doses.

Cycle Planner

Subcutaneous. Typical beginner frequency: weekly.

Cagrilintide Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = ~7 days
50%25%12.5%100%75%50%25%0%07d14d21d28d35dTime after injectionDose remaining
After 1 half-life (7d): 50% remainsAfter 2 half-lives (14d): 25% remainsAfter 3 half-lives (21d): 12.5% remains
At a 1.2mg dose: 50% = 600mcg remaining after 7d. Recommended frequency: Weekly.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Cagrilintide Dosing Protocol

LevelDose / InjectionFrequency
Beginner500mcgWeekly
Moderate1,200mcgWeekly
Aggressive2,400mcgWeekly

Note: Long-acting amylin analog. Different mechanism than GLP-1 agonists. Titrate slowly from 0.5mg. Can be combined with semaglutide (CagriSema).

About Cagrilintide

Cagrilintide is a long-acting amylin receptor agonist that works through a completely different pathway than GLP-1 drugs like semaglutide. Amylin is naturally released by the pancreas after meals to promote satiety. Cagrilintide mimics this effect, reducing cravings and slowing gastric emptying. It's being studied both alone and in combination with semaglutide (CagriSema) for enhanced weight loss.

Frequently Asked Questions